The global market for Analgesics is estimated at US$51.1 Billion in 2023 and is projected to reach US$72.8 Billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the analgesics market is driven by several factors. Advancements in drug delivery systems have made analgesics more effective and user-friendly, with innovations like patient-controlled analgesia pumps and wearable drug delivery devices gaining popularity. The rising prevalence of chronic diseases such as arthritis and cancer, which often require long-term pain management, has also fueled demand for analgesics. Additionally, an aging global population is contributing to increased consumption of these medications, as older adults are more likely to experience chronic pain conditions. Consumer behavior trends show a growing preference for over-the-counter analgesics for quick and accessible pain relief, further boosting market growth. Moreover, increased healthcare spending and greater access to medical care in developing regions are expanding the market`s reach. Pharmaceutical companies are also investing heavily in research and development to create new analgesics with better safety profiles and effectiveness, responding to the growing demand for safer alternatives to traditional painkillers. These factors collectively underscore the dynamic and expanding nature of the analgesics market.
The growth in the analgesics market is driven by several factors. Advancements in drug delivery systems have made analgesics more effective and user-friendly, with innovations like patient-controlled analgesia pumps and wearable drug delivery devices gaining popularity. The rising prevalence of chronic diseases such as arthritis and cancer, which often require long-term pain management, has also fueled demand for analgesics. Additionally, an aging global population is contributing to increased consumption of these medications, as older adults are more likely to experience chronic pain conditions. Consumer behavior trends show a growing preference for over-the-counter analgesics for quick and accessible pain relief, further boosting market growth. Moreover, increased healthcare spending and greater access to medical care in developing regions are expanding the market`s reach. Pharmaceutical companies are also investing heavily in research and development to create new analgesics with better safety profiles and effectiveness, responding to the growing demand for safer alternatives to traditional painkillers. These factors collectively underscore the dynamic and expanding nature of the analgesics market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Prescription Analgesics segment, which is expected to reach US$43.8 Billion by 2030 with a CAGR of a 4.9%. The OTC Analgesics segment is also set to grow at 5.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $16.5 Billion in 2023, and China, forecasted to grow at an impressive 7.0% CAGR to reach $10.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Analgesics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Analgesics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Analgesics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bristol-Myers Squibb Company, Bayer AG, Biological E. Ltd., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 146 Featured):
- Bristol-Myers Squibb Company
- Bayer AG
- Biological E. Ltd.
- Anabolic Laboratories LLC
- BioDelivery Sciences International, Inc.
- Brawn Laboratories Ltd.
- Angelini Holding S.p.A.
- AFT Pharmaceuticals Limited
- APT Asia Pacific
- Church & Dwight (Australia) Pty Ltd.
- Alliance Design and Development Group, Inc.
- Active Releaf Wellness Inc.
- Abiogen Pharma S.p.A.
- B-New Limited
- Celgene Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- Bristol-Myers Squibb Company
- Bayer AG
- Biological E. Ltd.
- Anabolic Laboratories LLC
- BioDelivery Sciences International, Inc.
- Brawn Laboratories Ltd.
- Angelini Holding S.p.A.
- AFT Pharmaceuticals Limited
- APT Asia Pacific
- Church & Dwight (Australia) Pty Ltd.
- Alliance Design and Development Group, Inc.
- Active Releaf Wellness Inc.
- Abiogen Pharma S.p.A.
- B-New Limited
- Celgene Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 578 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 51.1 Billion |
| Forecasted Market Value ( USD | $ 72.8 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
